US2002143283A1PendingUtilityA1

Material for removing beta-2 microglobulin from blood

Priority: Jul 30, 1997Filed: May 7, 2002Published: Oct 3, 2002
Est. expiryJul 30, 2017(expired)· nominal 20-yr term from priority
B01J 20/2805B01J 20/265B01J 20/3278B01J 20/321Y10S210/905B01J 20/327A61M 1/3679B01J 20/264B01J 20/261B01J 20/3251B01J 2220/62B01J 2220/58B01J 20/3248A61M 2202/0421B01J 20/3255B01J 20/28078B01J 20/3092B01J 20/3272B01J 20/3064A61M 1/16
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A material for removing beta-2 microglobulin from blood by passing the blood through the material which are hydrophilic and biocompatible a size and a structure selected so as to remove beta-2 microglobulin from the blood, wherein said material is a porous beaded polydivinylbenzene or polystyrene-co-polydivinylbenzene polymer with a surface of [the] beads and of pores modified so as to prevent adsorption of large proteins and platelets and to minimize activation of blood complement system without affecting noticeably accessibility of an inner absorption space of the beads for beta-2 microglobulin and middle-sized toxicant molecules, in which polymer surface exposed vinyl groups are chemically modified so as to form different surface exposed functional groups which are hydrophilic and biocompatible.

Claims

exact text as granted — not AI-modified
1 . A material for removing beta-2 microglobulin from blood by passing the blood through the material which are hydrophilic and biocompatible a size and a structure selected so as to remove beta-2 microglobulin from the blood, wherein said material is a porous beaded polydivinylbenzene or polystyrene-co-polydivinylbenzene polymer with a surface of beads and of pores modified so as to prevent adsorption of large proteins and platelets and to minimize activation of blood complement system without affecting noticeably accessibility of an inner absorption space of the beads for beta-2 microglobulin and middle-sized toxicant molecules, in which polymer surface exposed vinyl groups are chemically modified so as to form different surface exposed functional groups which are hydrophilic and biocompatible.  
     
     
         2 . A material for removing beta-2 microglobulin from blood as defined in  claim 1 , wherein the beads contain more than 50% of divinylenzene.  
     
     
         3 . A material for removing beta-2 microglobulin from blood as defined in  claim 1 , wherein the beads contain more than 60% of divinylenzene.  
     
     
         4 . A material for removing beta-2 microglobulin from blood as defined in  claim 1 , wherein the beads contain more than 75% of divinylenzene.  
     
     
         5 . A material for removing beta-2 microglobulin from blood as defined in  claim 1 , wherein the beads contain 55% of divinylenzene.  
     
     
         6 . A material for removing beta-2 microglobulin from blood as defined in  claim 1 , wherein the beads contain 65% of divinylenzene.  
     
     
         7 . A material for removing beta-2 microglobulin from blood as defined in  claim 1 , wherein the beads contain 80% of divinylenzene.

Join the waitlist — get patent alerts

Track US2002143283A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.